Status:
UNKNOWN
The Gastric HormonE BioMarkers of Preneoplastic Lesions Study
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
University College, London
University of Oxford
Conditions:
Stomach Neoplasm
Chronic Atrophic Gastritis
Eligibility:
All Genders
18-80 years
Brief Summary
The goal of the study is to understand whether blood levels of hormones produced or metabolized in the stomach reflect the health of the stomach lining. Specifically the study will determine whether ...
Detailed Description
Previously published promising data show that blood levels of ghrelin, gastrin, vitamin B12 and pepsinogen are each associated with risk of developing stomach cancer. These studies used blood bank sam...
Eligibility Criteria
Inclusion
- Adult patients (18-80 years old) attending upper gastrointestinal endoscopy.
- Patients able to read and comprehend English.
- Patients willing and able to provide informed consent.
- Patients willing and able to provide a venous blood sample.
Exclusion
- Any individual diagnosed with gastric cancer, or with a history of gastric cancer, prior gastrectomy or bariatric surgery.
- Any individual with a chronic inflammatory condition of the gastrointestinal tract (Crohn's disease or ulcerative colitis).
- Once enrolment ceiling is reached for each group, enrolment will close for that group. The study will continue until all groups are complete.
Key Trial Info
Start Date :
November 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 2 2024
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06085677
Start Date
November 4 2023
End Date
September 2 2024
Last Update
October 17 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.